Back to CRNX
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
1 competitor in SST2-positive Neuroendocrine Neoplasms
View Full LandscapeDrug Information
Target Indication
SST2-positive Neuroendocrine Neoplasms
Clinical Trial
NCT07129252Last updated: 12/4/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts